Papers
36
Total Citations
754
H-Index
13
About
Zhe Jing is a leading figure in robotic urologic oncology, whose research has fundamentally shaped the modern surgical management of bladder cancer. Dr. Jing’s primary contributions center on optimizing robot-assisted radical cystectomy (RARC), with a particular focus on comparing intracorporeal versus extracorporeal urinary diversion. Through landmark analyses of the International Robotic Cystectomy Consortium (IRCC) database—including studies cited over 200 and nearly 90 times—Dr. Jing demonstrated that intracorporeal diversion offers superior perioperative outcomes, establishing a new standard of care. Further work, cited over 70 times, provided crucial ten-year oncologic data confirming the long-term efficacy of the robotic approach. Dr. Jing has also advanced the field by validating surgical risk calculators and exploring the transition to next-generation robotic platforms like the Versius system. Notably, Dr. Jing’s research extends beyond urology into cognitive neuroscience, developing models to evaluate surgical workload and performance using functional brain network analysis. This interdisciplinary work, with papers cited nearly 20 times, underscores a unique commitment to understanding the human factors in surgery. With a portfolio of highly cited, practice-changing studies, Zhe Jing is a pivotal voice in the evolution of minimally invasive urologic surgery.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10